DOTmed.com - Alzheimer's disease PET scan guidelines released for first time
SEARCH
Current Location:
>
> This Story

starstarstarstarstar (1)
Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

Never Miss a Story

Sign up for email alerts

 

More Industry Headlines

Health care survey finds doctors, patients OK now, but fear for future Survey: Patients happy with service now, but afraid for future. Doctors fear future cost-pressures

Memorial Sloan Kettering, IBM looking at computerized skin cancer lesion identification Image mapping could guide the way to more accurate diagnoses

Philips acquires catheter-based imaging co., Volcano May help Philips break into EUR four billion image-guided therapy market

XR-29's lower dose CT requirements: Will iterative reconstruction play a role? As the industry inches toward new dose requirements, some implementation questions remain

Is Obamacare causing emergency room crowding? No, says new study The Affordable Care Act is not the cause of the problem. It comes from a primary care shortage

Could microwave tomography replace mammography? New experimental technique offers greater specificity with no radiation or patient discomfort

Hitachi partners with iVu for automated whole breast ultrasound

Fetal keepsake ultrasound videos have "potential for harm": FDA expert Time to find a new way to capture memories

Olympus' imaging technology for bladder biopsies gets FDA nod May allow for in-office treatment

Urban health - big cities, big challenges In July, the Carolinas HealthCare System Anson in Wadesboro, N.C., a town of about 5,800 people, opened the doors to its new facility and embarked on a bold experiment.

Dr. Minoshima,
co-author of the appropriate use criteria.

Alzheimer's disease PET scan guidelines released for first time

by Nancy Ryerson , Staff Writer
Before new PET technology came on the scene, physicians could only examine the brains of Alzheimer's disease patients once they died. Now, new PET images can show the brain plaques characteristic of Alzheimer's disease in living patients, technology that, while ground-breaking, is expensive and may not produce useful results for every patient. On Jan. 28, the Society of Nuclear Medicine and Molecular Imaging and the Alzheimer's Association co-released guidelines that give physicians, patients and family members the tools to determine whether the cutting-edge tests are right for a patient.

"Even though it's really exciting new technology, which we are certain will contribute to patient care, because of the expense as well as it's not [being a] perfect test, we want to really carefully integrate this technology for the best care of the patient," said Dr. Satoshi Minoshima, SNMMI member and co-author of the appropriate use criteria. "That's really the reason for creating this appropriate use criteria."

Story Continues Below Advertisement

OiHealthcare - ISO 9001 & 13485 Certified - Call 888-673-5151

Oxford Instruments Healthcare, is a leading ISO 9001 & 13485-certified organization, that specializes in providing quality after-market GE CT and MRI systems, service and parts - at prices you can afford.



Dr. Minoshima explained that the test, still in its early stages, has about a 90 to 95 percent accuracy rate. And results can be misleading if used on the wrong patients. Elevated beta-amyloid plaques are one of the defining signs of Alzheimer's disease, but for reasons unknown, the plaques can sometimes appear on seemingly healthy brains as well.

Also, many cases of Alzheimer's can be diagnosed without the use of scans. The guidelines suggest using them for cases when a person younger than 65 is showing symptoms, or if the case is more difficult to diagnose, such as if the patient had a stroke recently and is already showing some cognitive decline.

"In clinical diagnosis, it's very difficult to distinguish Alzheimer's disease if the patient had a stroke," said Dr. Minoshima. "Having PET imaging, that shows really positive amyloid deposition, really helps atypical cases like that."

The guidelines also note that the tests are inappropriate when used to determine the severity of dementia, when requested, based solely on family history of dementia or Alzheimer's disease and for non-medical reasons, such as insurance.

The SNMMI team combed through medical journals and sought comments from nuclear medicine professionals in order to develop the guidelines. Dr. Minoshima hopes the guidelines will help physicians get the most out of the emerging technology.

Related:


Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Center
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2014 DOTmed.com, Inc.
ALL RIGHTS RESERVED